The process can be beneficial in mitigating the spread of a virus. Monkeys infected with COVID-19 that were treated with remdesivir, a drug from Gilead Sciences Inc., were shown to be in “significantly better health” than those who were untreated, according to a new study from the National Institutes of Health (NIH).
The health organization shared the findings in a news release on April 17, noting that the amount of virus in the lungs of the monkeys who had received remdesivir was “significantly lower” than another group of monkeys who had received no treatment.
Additionally, monkeys in the treated group also had less damage caused to their lungs by COVID-19 than the non-treated group.RELATED: CoronavirusNOW.com, FOX launches national hub